---
layout: post
title: "东曜药业-B(01875)发布第一季度业绩 营业收入同比增长450.25%至8024.9万元"
date: 2022-05-12 20:37:33 +0800
categories: zhitongcaijingwang
tags: 智通财经网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.01875" data-code="01875|116|5" data-code2="01875|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.01875&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 01875_0" data-code="K 01875|116|5" data-code2="K 01875|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>东曜药业-B(01875)发布2022年第一季度业绩，营业收入同比增长450.25%至人民币8024.9万元，主要系集团自研产品销量大幅度增加及集团项目的里程碑授权金收入增加所致。<br /></p><p class="em_media">（文章来源：智通财经网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202205122377537312>

[返回智通财经网新闻](//finews.withounder.com/category/zhitongcaijingwang.html)｜[返回首页](//finews.withounder.com/)